Mechanisms of antitumor and immune-enhancing activities of MUC1/sec, a secreted form of mucin-1

Dan Ilkovitch, Roberto Carrio, Diana M Lopez

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Mucin 1 (MUC1) is a polymorphic type 1 transmembrane protein found on the apical surface of normal cells lining the lumen of ducts and glands. Mucins are thought to provide mucosal protection from environmental exposures and carcinogens. An altered form of the MUC1 glycoprotein, which is hypoglycosylated, is expressed in several types of human cancers. In our laboratory, we have found that transfection of a murine mammary tumor cell line with a human secreted isoform of MUC1 rendered these DA-3 cells (DA-3/sec) incapable of growing in intact BALB/c mice. In contrast, implantation of DA-3 cells transfected with the human transmembrane isoform of MUC1 (DA-3/TM), resulted in tumor formation and ultimately death of the animals, similar to the DA-3 parental line. Importantly, inoculation of the DA-3/sec cells in immunodeficient nude mice resulted in tumor formation, indicating that the MUC1/sec molecule's antitumor activity is immunologically controlled. In this review, we summarize the studies we have performed to elucidate possible mechanisms for the immune-mediated antitumor effect of MUC1/sec and/or a unique peptide present in this mucin. Understanding these mechanisms may provide new immunotherapeutic approaches that could be used to target different types of cancer.

Original languageEnglish
Pages (from-to)70-80
Number of pages11
JournalImmunologic Research
Volume57
Issue number1-3
DOIs
StatePublished - Dec 1 2013

Fingerprint

Mucin-1
Mucins
Neoplasms
Protein Isoforms
Environmental Carcinogens
Environmental Exposure
Tumor Cell Line
Nude Mice
Transfection
Glycoproteins
Breast Neoplasms
Peptides
Proteins

Keywords

  • Antitumor activity
  • CCL2
  • Immune-enhancing peptide
  • MUC1 secreted form
  • Mucins
  • Myeloid-derived suppressor cells
  • STATs
  • Urokinase plasminogen activator

ASJC Scopus subject areas

  • Immunology

Cite this

Mechanisms of antitumor and immune-enhancing activities of MUC1/sec, a secreted form of mucin-1. / Ilkovitch, Dan; Carrio, Roberto; Lopez, Diana M.

In: Immunologic Research, Vol. 57, No. 1-3, 01.12.2013, p. 70-80.

Research output: Contribution to journalArticle

@article{05ebdc9aeac142e6b76e5dedbb013dc0,
title = "Mechanisms of antitumor and immune-enhancing activities of MUC1/sec, a secreted form of mucin-1",
abstract = "Mucin 1 (MUC1) is a polymorphic type 1 transmembrane protein found on the apical surface of normal cells lining the lumen of ducts and glands. Mucins are thought to provide mucosal protection from environmental exposures and carcinogens. An altered form of the MUC1 glycoprotein, which is hypoglycosylated, is expressed in several types of human cancers. In our laboratory, we have found that transfection of a murine mammary tumor cell line with a human secreted isoform of MUC1 rendered these DA-3 cells (DA-3/sec) incapable of growing in intact BALB/c mice. In contrast, implantation of DA-3 cells transfected with the human transmembrane isoform of MUC1 (DA-3/TM), resulted in tumor formation and ultimately death of the animals, similar to the DA-3 parental line. Importantly, inoculation of the DA-3/sec cells in immunodeficient nude mice resulted in tumor formation, indicating that the MUC1/sec molecule's antitumor activity is immunologically controlled. In this review, we summarize the studies we have performed to elucidate possible mechanisms for the immune-mediated antitumor effect of MUC1/sec and/or a unique peptide present in this mucin. Understanding these mechanisms may provide new immunotherapeutic approaches that could be used to target different types of cancer.",
keywords = "Antitumor activity, CCL2, Immune-enhancing peptide, MUC1 secreted form, Mucins, Myeloid-derived suppressor cells, STATs, Urokinase plasminogen activator",
author = "Dan Ilkovitch and Roberto Carrio and Lopez, {Diana M}",
year = "2013",
month = "12",
day = "1",
doi = "10.1007/s12026-013-8451-6",
language = "English",
volume = "57",
pages = "70--80",
journal = "Immunologic Research",
issn = "0257-277X",
publisher = "Humana Press",
number = "1-3",

}

TY - JOUR

T1 - Mechanisms of antitumor and immune-enhancing activities of MUC1/sec, a secreted form of mucin-1

AU - Ilkovitch, Dan

AU - Carrio, Roberto

AU - Lopez, Diana M

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Mucin 1 (MUC1) is a polymorphic type 1 transmembrane protein found on the apical surface of normal cells lining the lumen of ducts and glands. Mucins are thought to provide mucosal protection from environmental exposures and carcinogens. An altered form of the MUC1 glycoprotein, which is hypoglycosylated, is expressed in several types of human cancers. In our laboratory, we have found that transfection of a murine mammary tumor cell line with a human secreted isoform of MUC1 rendered these DA-3 cells (DA-3/sec) incapable of growing in intact BALB/c mice. In contrast, implantation of DA-3 cells transfected with the human transmembrane isoform of MUC1 (DA-3/TM), resulted in tumor formation and ultimately death of the animals, similar to the DA-3 parental line. Importantly, inoculation of the DA-3/sec cells in immunodeficient nude mice resulted in tumor formation, indicating that the MUC1/sec molecule's antitumor activity is immunologically controlled. In this review, we summarize the studies we have performed to elucidate possible mechanisms for the immune-mediated antitumor effect of MUC1/sec and/or a unique peptide present in this mucin. Understanding these mechanisms may provide new immunotherapeutic approaches that could be used to target different types of cancer.

AB - Mucin 1 (MUC1) is a polymorphic type 1 transmembrane protein found on the apical surface of normal cells lining the lumen of ducts and glands. Mucins are thought to provide mucosal protection from environmental exposures and carcinogens. An altered form of the MUC1 glycoprotein, which is hypoglycosylated, is expressed in several types of human cancers. In our laboratory, we have found that transfection of a murine mammary tumor cell line with a human secreted isoform of MUC1 rendered these DA-3 cells (DA-3/sec) incapable of growing in intact BALB/c mice. In contrast, implantation of DA-3 cells transfected with the human transmembrane isoform of MUC1 (DA-3/TM), resulted in tumor formation and ultimately death of the animals, similar to the DA-3 parental line. Importantly, inoculation of the DA-3/sec cells in immunodeficient nude mice resulted in tumor formation, indicating that the MUC1/sec molecule's antitumor activity is immunologically controlled. In this review, we summarize the studies we have performed to elucidate possible mechanisms for the immune-mediated antitumor effect of MUC1/sec and/or a unique peptide present in this mucin. Understanding these mechanisms may provide new immunotherapeutic approaches that could be used to target different types of cancer.

KW - Antitumor activity

KW - CCL2

KW - Immune-enhancing peptide

KW - MUC1 secreted form

KW - Mucins

KW - Myeloid-derived suppressor cells

KW - STATs

KW - Urokinase plasminogen activator

UR - http://www.scopus.com/inward/record.url?scp=84891496578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891496578&partnerID=8YFLogxK

U2 - 10.1007/s12026-013-8451-6

DO - 10.1007/s12026-013-8451-6

M3 - Article

C2 - 24222275

AN - SCOPUS:84891496578

VL - 57

SP - 70

EP - 80

JO - Immunologic Research

JF - Immunologic Research

SN - 0257-277X

IS - 1-3

ER -